FOLD logo

Amicus Therapeutics, Inc. (FOLD) Total expenses

Annual total expenses:

$584.40M+$33.46M(+6.07%)
December 31, 2024

Summary

  • As of today (September 17, 2025), FOLD annual total expenses is $584.40 million, with the most recent change of +$33.46 million (+6.07%) on December 31, 2024.
  • During the last 3 years, FOLD annual total expenses has risen by +$28.43 million (+5.11%).
  • FOLD annual total expenses is now at all-time high.

Performance

FOLD Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

Quarterly total expenses:

$179.11M+$32.17M(+21.90%)
June 30, 2025

Summary

  • As of today (September 17, 2025), FOLD quarterly total expenses is $179.11 million, with the most recent change of +$32.17 million (+21.90%) on June 30, 2025.
  • Over the past year, FOLD quarterly total expenses has increased by +$36.74 million (+25.81%).
  • FOLD quarterly total expenses is now -0.36% below its all-time high of $179.76 million, reached on September 30, 2018.

Performance

FOLD Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

FOLD Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+6.1%+25.8%
3 y3 years+5.1%+25.4%
5 y5 years+8.5%+56.0%

FOLD Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+6.1%at high+55.8%
5 y5-yearat high+8.7%at high+56.0%
alltimeall timeat high+8535.1%-0.4%>+9999.0%

FOLD Total expenses History

DateAnnualQuarterly
Jun 2025
-
$179.11M(+21.9%)
Mar 2025
-
$146.94M(+8.9%)
Dec 2024
$584.40M(+6.1%)
$134.97M(-9.0%)
Sep 2024
-
$148.25M(+4.1%)
Jun 2024
-
$142.37M(-10.4%)
Mar 2024
-
$158.82M(+6.6%)
Dec 2023
$550.94M(-2.6%)
$148.93M(+19.1%)
Sep 2023
-
$125.08M(-9.2%)
Jun 2023
-
$137.74M(-1.1%)
Mar 2023
-
$139.20M(-3.3%)
Dec 2022
$565.80M(+1.8%)
$143.96M(+25.2%)
Sep 2022
-
$114.98M(-19.5%)
Jun 2022
-
$142.89M(-12.9%)
Mar 2022
-
$163.97M(-0.9%)
Dec 2021
$555.97M(+3.4%)
$165.43M(+27.4%)
Sep 2021
-
$129.84M(+0.9%)
Jun 2021
-
$128.64M(-2.6%)
Mar 2021
-
$132.07M(-7.0%)
Dec 2020
$537.74M(-0.2%)
$141.97M(+8.0%)
Sep 2020
-
$131.45M(+14.5%)
Jun 2020
-
$114.84M(-23.2%)
Mar 2020
-
$149.47M(+3.1%)
Dec 2019
$538.63M(+22.3%)
$145.02M(+31.2%)
Sep 2019
-
$110.58M(-14.1%)
Jun 2019
-
$128.68M(-16.6%)
Mar 2019
-
$154.34M(+39.4%)
Dec 2018
$440.24M(+37.2%)
$110.72M(-38.4%)
Sep 2018
-
$179.76M(+116.2%)
Jun 2018
-
$83.14M(+24.8%)
Mar 2018
-
$66.61M(-20.6%)
Dec 2017
$320.93M(+56.6%)
$83.94M(-31.5%)
Sep 2017
-
$122.54M(+121.6%)
Jun 2017
-
$55.29M(-6.5%)
Mar 2017
-
$59.16M(-3.8%)
Dec 2016
$205.00M(+55.2%)
$61.48M(+26.0%)
Sep 2016
-
$48.78M(-4.4%)
Jun 2016
-
$51.05M(+16.8%)
Mar 2016
-
$43.69M(+1.9%)
Dec 2015
$132.12M
$42.90M(+13.5%)
DateAnnualQuarterly
Sep 2015
-
$37.80M(+39.3%)
Jun 2015
-
$27.13M(+11.7%)
Mar 2015
-
$24.29M(+14.5%)
Dec 2014
$70.15M(+16.9%)
$21.22M(+21.7%)
Sep 2014
-
$17.44M(+15.6%)
Jun 2014
-
$15.09M(-8.0%)
Mar 2014
-
$16.40M(+30.6%)
Dec 2013
$60.00M(-10.7%)
$12.56M(-14.1%)
Sep 2013
-
$14.63M(-4.7%)
Jun 2013
-
$15.35M(-12.1%)
Mar 2013
-
$17.46M(+74.3%)
Dec 2012
$67.20M(+2.1%)
$10.02M(-38.5%)
Sep 2012
-
$16.29M(-18.5%)
Jun 2012
-
$19.98M(-4.5%)
Mar 2012
-
$20.91M(+46.3%)
Dec 2011
$65.85M(+17.9%)
$14.29M(-8.1%)
Sep 2011
-
$15.56M(-6.7%)
Jun 2011
-
$16.68M(-13.6%)
Mar 2011
-
$19.32M(+20.6%)
Dec 2010
$55.86M(-21.2%)
$16.01M(+4.3%)
Sep 2010
-
$15.36M(+35.7%)
Jun 2010
-
$11.31M(-14.1%)
Mar 2010
-
$13.18M(-20.2%)
Dec 2009
$70.92M(+30.6%)
$16.52M(-9.9%)
Sep 2009
-
$18.34M(-3.4%)
Jun 2009
-
$18.98M(+11.2%)
Mar 2009
-
$17.08M(-7.7%)
Dec 2008
$54.32M(+26.5%)
$18.50M(+56.3%)
Sep 2008
-
$11.83M(-9.7%)
Jun 2008
-
$13.10M(+20.3%)
Mar 2008
-
$10.89M(-19.7%)
Dec 2007
$42.95M(-34.9%)
$13.56M(+31.6%)
Sep 2007
-
$10.30M(+9.7%)
Jun 2007
-
$9.40M(-3.1%)
Mar 2007
-
$9.69M(>+9900.0%)
Dec 2006
$65.93M(+227.8%)
$0.00(0.0%)
Dec 2005
$20.11M(+125.1%)
$0.00
Dec 2004
$8.93M(+32.0%)
-
Dec 2003
$6.77M
-

FAQ

  • What is Amicus Therapeutics, Inc. annual total expenses?
  • What is the all time high annual total expenses for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. annual total expenses year-on-year change?
  • What is Amicus Therapeutics, Inc. quarterly total expenses?
  • What is the all time high quarterly total expenses for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. quarterly total expenses year-on-year change?

What is Amicus Therapeutics, Inc. annual total expenses?

The current annual total expenses of FOLD is $584.40M

What is the all time high annual total expenses for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high annual total expenses is $584.40M

What is Amicus Therapeutics, Inc. annual total expenses year-on-year change?

Over the past year, FOLD annual total expenses has changed by +$33.46M (+6.07%)

What is Amicus Therapeutics, Inc. quarterly total expenses?

The current quarterly total expenses of FOLD is $179.11M

What is the all time high quarterly total expenses for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high quarterly total expenses is $179.76M

What is Amicus Therapeutics, Inc. quarterly total expenses year-on-year change?

Over the past year, FOLD quarterly total expenses has changed by +$36.74M (+25.81%)
On this page